Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:55-62
Published online before print November 2, 2006, doi: 10.1161/01.ATV.0000251535.30191.60
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
27/1/55    most recent
01.ATV.0000251535.30191.60v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schäfer, A.
Right arrow Articles by Bauersachs, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schäfer, A.
Right arrow Articles by Bauersachs, J.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:55.)
© 2007 American Heart Association, Inc.


Vascular Biology

The CX3C Chemokine Fractalkine Induces Vascular Dysfunction by Generation of Superoxide Anions

Andreas Schäfer; Christian Schulz; Daniela Fraccarollo; Piet Tas; Meike Leutke; Martin Eigenthaler; Stefan Seidl; Peter Heider; Georg Ertl; Steffen Massberg; Johann Bauersachs

From Medizinische Klinik und Poliklinik I (A.S., D.F., M.L., G.E., J.B.), Universitätsklinikum, Julius-Maximilians-Universität Würzburg, Germany; Deutsches Herzzentrum und 1. Medizinische Klinik (C.S., S.M.), Technische Universität München, Germany; Klinik und Poliklinik für Anästhesiologie (P.T.), Universitätsklinikum, Julius-Maximilians-Universität Würzburg, Germany; Institut für Klinische Biochemie und Pathobiochemie (M.E.), Julius-Maximilians-Universität Würzburg, Germany; Institut für Pathologie (S.S.), Klinikum rechts der Isar, Technische Universität München, Germany; Abteilung Gefässchirurgie (P.H.), Klinikum rechts der Isar, Technische Universität München, Germany.

Correspondence to Andreas Schäfer, Medizinische Klinik und Poliklinik I, Universitätsklinikum Würzburg, Josef-Schneider-Str. 2, 97080 Würzburg, Germany. E-mail a.schaefer{at}medizin.uni-wuerzburg.de

Objective— The chemokine fractalkine activates platelets and induces leukocyte adhesion to the endothelium. Expression of fractalkine and its receptor, CX3CR1, is elevated in coronary artery disease. We assessed the effects of fractalkine on vascular function in isolated rat aorta.

Methods and Results— CX3CR1 expression was demonstrated in rat aortic endothelial and smooth muscle cells by immunohistochemistry, Western blot, and polymerase chain reaction (PCR). Fractalkine (up to 1 µg/mL) did not directly induce contractile or relaxant responses when applied to rat aortic rings in organ baths. Short-term incubation with fractalkine (1 µg/mL) for 5 minutes did not affect vascular reactivity. Pretreatment of isolated rat aortic rings with fractalkine for 2 hours impaired acetylcholine-induced nitric oxide (NO)-mediated relaxation after preconstriction with phenylephrine in a concentration-dependent manner. The concentration response to the NO donor DEA-NONOate was significantly shifted to the right. The radical scavenger tiron normalized the attenuated acetylcholine-induced relaxation after fractalkine incubation. Aortic superoxide formation was enhanced by fractalkine, which was inhibited by diphenyleneiodonium but not by inhibitors of xanthine oxidase or NO synthase.

Conclusion— In addition to its role as a chemokine and adhesion molecule, fractalkine induces vascular dysfunction by stimulating vascular reactive oxygen species resulting in reduced NO bioavailability.

We investigated direct effects of fractalkine on vascular function. We demonstrate increased superoxide formation and decreased nitric oxide bioavailability in rat aorta by fractalkine. Induction of vascular dysfunction could provide an alternate mechanism by which fractalkine exerts its pro-atherosclerotic effects.


Key Words: chemokines • endothelial dysfunction • nitric oxide • reactive oxygen species




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. C. Sullivan, J. L. Pardieck, D. Doran, Y. Zhang, J.-X. She, and J. S. Pollock
Greater fractalkine expression in mesenteric arteries of female spontaneously hypertensive rats compared with males
Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H1080 - H1088.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Zernecke, E. Shagdarsuren, and C. Weber
Chemokines in Atherosclerosis: An Update
Arterioscler. Thromb. Vasc. Biol., November 1, 2008; 28(11): 1897 - 1908.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
X. P. Yang, S. Mattagajasingh, S. Su, G. Chen, Z. Cai, K. Fox-Talbot, K. Irani, and L. C. Becker
Fractalkine Upregulates Intercellular Adhesion Molecule-1 in Endothelial Cells Through CX3CR1 and the Jak Stat5 Pathway
Circ. Res., November 9, 2007; 101(10): 1001 - 1008.
[Abstract] [Full Text] [PDF]